NIH Wants to Tell Clinical Trial Guinea Pigs the Results
Published Date: 9/25/2026
Notice
Summary
The NIH wants to make it easier for people who join clinical studies to get simple summaries of the study results. This new policy aims to boost trust and teamwork between researchers and participants, helping science move faster and better. They’re asking for your thoughts by October 26, 2026, so get ready to share your ideas!
Analyzed Economic Effects
5 provisions identified: 4 benefits, 1 costs, 0 mixed.
Mandatory plain‑language results for participants
If a study is supported in whole or in part by NIH, researchers and institutions must responsibly share summary level study results in plain language with clinical research participants, unless sharing is justifiably not appropriate and an exception is approved. This requirement applies to all NIH‑supported clinical research, including intramural studies.
Deadlines for sharing study summaries
For NIH‑supported clinical trials, summary level study results must be shared no later than one year after the study's primary completion date or by the date results must be reported in ClinicalTrials.gov under NIH policy, whichever is later. For extramural clinical research that is not a clinical trial, summaries must be shared no later than the end of the period of performance if analyses are complete, or a status update must be provided. For all intramural clinical research, annual status updates to participants are required beginning no later than six months after the policy effective date.
Funding consequences for noncompliance
All recipients of NIH support for clinical research must comply with the Policy; failure to comply may lead to enforcement actions such as additional special terms and conditions, termination, or other actions that may affect future NIH funding decisions for the recipient institution, consistent with applicable grant regulations and procedures.
Participants must be offered results option
Researchers must ensure that research participants are offered summary level study results, whether or not participants ultimately receive those results. If sharing will not occur, researchers should request an exception (generally before enrollment) and if sharing becomes impossible must inform participants why sharing is no longer possible.
NIH may provide supplemental guidance and support
NIH is considering issuing supplemental guidance and resources to help researchers share summary level study results in plain language, and is seeking input on the types of activities and anticipated costs needed to implement this requirement for different kinds of studies.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-19431, Government-Owned Inventions; Availability for Licensing
The government is offering a new invention for licensing that makes stem cell transplants safer and less harsh, especially for leukemia patients and older folks. This tech uses a special protein to prepare patients for transplants without the tough side effects of chemo and radiation. Companies can start licensing this preclinical innovation now to help bring better treatments to market faster.
2026-19303, Submission for OMB review; 30-Day Comment Request; the Impact and Costs of Promoting Objectivity in Research 42 CFR Part 50 Subpart F and Responsible Prospective Contractors 45 CFR Part 94 (Office of the Director)
The National Institutes of Health (NIH) is asking for your thoughts on how they collect info to keep research honest and fair. This affects researchers and contractors who work with NIH, aiming to make sure everything stays clear and trustworthy. You’ve got until October 22, 2026, to share your comments—no cost changes, just a check-in to keep things running smoothly!
2026-19155, Proposed Collection; 60-Day Comment Request; PHS Applications and Pre-Award Reporting Requirements (OD)
The NIH is updating how researchers submit their Public Health Service applications and reports before awards, starting May 25, 2026. This change aims to make data management clearer and easier, affecting anyone applying for NIH funding. They want your feedback by November 17, 2026, to help improve the process without adding extra hassle or costs.
2026-19156, Proposed Collection; 60-Day Comment Request; Post-Award Reporting Requirements Including Research Performance Progress Report (OD)
The National Institutes of Health (NIH) wants your thoughts on updating how researchers report their progress after getting awards. This affects anyone who receives NIH funding and aims to make reporting clearer and less of a hassle. Comments are due by November 17, 2026, so don’t miss your chance to weigh in!
2026-18937, Proposed Collection; 60-Day Comment Request; NIH Intramural Reporting of Research Misconduct (IRRM) Web Form (Office of the Director/Office of Intramural Research)
The NIH is rolling out a new online form to make reporting research cheating easier and fairer. Anyone involved with NIH research can use this form to report problems like lying or copying, even anonymously. They want your feedback by November 16, 2026, to make sure the form works well without causing extra hassle.
2026-18877, Prospective Grant of an Exclusive Patent License: Development and Commercialization of Engineered Cell Therapies for the Treatment of HPV 16 E6-Expressing Cancers
The National Cancer Institute plans to give MedGene Therapeutics an exclusive license to develop and sell special engineered cell treatments for cancers caused by HPV 16 E6. This means MedGene will have the sole right to use these inventions, potentially speeding up new cancer therapies. If you want to comment or apply for a license, you must do so by September 30, 2026.
Previous / Next Documents
Previous: 2026-19704, Robotically-Assisted Surgical Devices-Premarket Submissions; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
The FDA just dropped a draft guide for companies making robot-assisted surgical devices, showing how to get their products approved before selling. If you’re in the biz, now’s the time to check it out and send your feedback by November 24, 2026. This guide aims to make the approval process clearer and smoother, potentially saving time and money down the road.
Next: 2026-19707, Medicaid and Children's Health Insurance Program (CHIP) Generic Information Collection Activities: Proposed Collection; Comment Request
The Centers for Medicare & Medicaid Services (CMS) wants your thoughts on their plan to keep collecting simple, low-burden info about Medicaid and CHIP programs. This helps them improve how they manage state plans, waivers, and reports without causing extra hassle. If you have ideas or concerns, speak up by October 9, 2026—your input can shape smoother healthcare paperwork!